<DOC>
	<DOCNO>NCT00089895</DOCNO>
	<brief_summary>The purpose study see early INTEGRILINÂ® ( eptifibatide ) therapy patient non-ST-segment elevation acute coronary syndrome ( ACS ) reduce occurence death , heart attack urgent cardiac intervention ( surgery ) compare placebo ( delayed provisional use eptifibatide ) .</brief_summary>
	<brief_title>EARLY ACS : Early Glycoprotein IIb/IIIa Inhibition Patients With Non-ST-segment Elevation Acute Coronary Syndrome ( Study P03684AM2 ) ( COMPLETED )</brief_title>
	<detailed_description>This study enroll patient experience symptom acute coronary syndrome ( experience chest pain rest episodes last least 10 minute ) plan undergo invasive surgical procedure give study drug 12 96 hour . There two different treatment group study ; approximately half patient go group likelihood receive study drug vs. placebo 50/50 ( like toss coin ) . Medications standard care provide patient ( patient give aspirin standard hospital dose one two blood thin drug - unfractionated heparin ( UFH ) low-molecular-weight heparin ) . Which one patient receive discretion Investigator .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Eptifibatide</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Willing able give inform consent comply study procedure followup 1 year . Plan undergo invasive strategy receive study drug 12 96 hour . Able randomized trial within 12 hour symptom acute coronary syndrome . Experiencing symptoms cardiac ischemia rest ( angina anginal equivalent ) episode ( ) last least 10 minute least 2 follow : 60 year age Electrocardiogram change ( ECG ) Elevated troponin ( protein release blood stream people suffer acute coronary syndrome ) CKMB level Or 3 following : Prior history cardiovascular disease Elevated troponin CKMB level 5059 year age pregnancy ( know suspect ) renal dialysis within 30 day prior randomize study serious illness condition investigator feel would pose significant hazard patient investigational therapy initiate Stroke ( hemorrhagic stroke time nonhemorrhagic stroke within previous 7 day ) , central nervous system damage ( neoplasm , aneurysm , intracranial surgery ) , bleed disorder ( include gastrointestinal bleeding ) , recent major surgery major trauma . History certain hematologic problem follow treatment heparin eptifibatide . Therapy certain related drug within short time randomization trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>acute coronary syndrome</keyword>
	<keyword>non-ST-segment elevation</keyword>
	<keyword>eptifibatide</keyword>
	<keyword>Integrilin</keyword>
	<keyword>glycoprotein IIb/IIIa inhibitor ( GP IIb/IIIa )</keyword>
	<keyword>percutaneous coronary intervention ( PCI )</keyword>
	<keyword>coronary artery bypass graph surgery ( CABG )</keyword>
	<keyword>catheterization</keyword>
	<keyword>angina</keyword>
	<keyword>ischemia</keyword>
	<keyword>cardiac ischemia</keyword>
	<keyword>cardiovascular disease</keyword>
</DOC>